| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 11395184
[patent_doc_number] => 20170015719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST'
[patent_app_type] => utility
[patent_app_number] => 13/952068
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6403
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952068
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952068 | CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST | Jul 25, 2013 | Abandoned |
Array
(
[id] => 10945841
[patent_doc_number] => 20140348862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Prame derived peptides and immunogenic compositions comprising these'
[patent_app_type] => utility
[patent_app_number] => 13/945335
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16155
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945335
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/945335 | Prame derived peptides and immunogenic compositions comprising these | Jul 17, 2013 | Issued |
Array
(
[id] => 9160983
[patent_doc_number] => 20130309260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'HUMAN CYTOTOXIC T-LYMPHOCYTE EPITOPE AND ITS AGONIST EPITOPE FROM THE NON-VARIABLE NUMBER OF TANDEM REPEAT SEQUENCE OF MUC-1'
[patent_app_type] => utility
[patent_app_number] => 13/941705
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38423
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941705
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/941705 | Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 | Jul 14, 2013 | Issued |
| 13/701299 | XYXIN FRAGMENT BIOMARKER FOR DIAGNOSIS OF COLON CANCER | Jul 11, 2013 | Abandoned |
Array
(
[id] => 9122339
[patent_doc_number] => 20130289261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 13/939988
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17090
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939988
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/939988 | Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen | Jul 10, 2013 | Issued |
Array
(
[id] => 9792678
[patent_doc_number] => 20150004621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'BIOLOGICAL MARKER FOR EARLY CANCER DETECTION AND METHODS FOR CANCER DETECTION (BF819)'
[patent_app_type] => utility
[patent_app_number] => 13/931432
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26463
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931432
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/931432 | BIOLOGICAL MARKER FOR EARLY CANCER DETECTION AND METHODS FOR CANCER DETECTION (BF819) | Jun 27, 2013 | Abandoned |
Array
(
[id] => 9081430
[patent_doc_number] => 20130266960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Methods And Kits For Differential Staining Of Abnormal Urinary System Cells'
[patent_app_type] => utility
[patent_app_number] => 13/900055
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10843
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900055
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900055 | Methods And Kits For Differential Staining Of Abnormal Urinary System Cells | May 21, 2013 | Abandoned |
Array
(
[id] => 10283411
[patent_doc_number] => 20150168409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'METHOD FOR DETERMINING IF A SUBJECT HAS AN INCREASED LIKELIHOOD OF HIGH GRADE DYSPLASIA OR ESOPHAGEAL ADENOCARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 14/402034
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20847
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402034 | METHOD FOR DETERMINING IF A SUBJECT HAS AN INCREASED LIKELIHOOD OF HIGH GRADE DYSPLASIA OR ESOPHAGEAL ADENOCARCINOMA | May 16, 2013 | Abandoned |
Array
(
[id] => 9546726
[patent_doc_number] => 20140171374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/895756
[patent_app_country] => US
[patent_app_date] => 2013-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 25914
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895756
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/895756 | USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS | May 15, 2013 | Abandoned |
Array
(
[id] => 9269114
[patent_doc_number] => 20140024030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH OXYGEN SENSITIVE AGENTS BASED IN HYPOXIC STATUS'
[patent_app_type] => utility
[patent_app_number] => 13/895709
[patent_app_country] => US
[patent_app_date] => 2013-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 61715
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/895709 | PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH OXYGEN SENSITIVE AGENTS BASED IN HYPOXIC STATUS | May 15, 2013 | Abandoned |
| 13/895543 | METHODS FOR TREATING CANCER WITH NOTCH2/3 ANTIBODIES | May 15, 2013 | Abandoned |
Array
(
[id] => 9134866
[patent_doc_number] => 20130295581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Methods and Compositions for the Treatment and Diagnosis of Breast Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/888254
[patent_app_country] => US
[patent_app_date] => 2013-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13888254
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/888254 | Methods and Compositions for the Treatment and Diagnosis of Breast Cancer | May 5, 2013 | Abandoned |
Array
(
[id] => 9033858
[patent_doc_number] => 20130236497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'TREATING NEOPLASMS WITH NEUROTOXIN'
[patent_app_type] => utility
[patent_app_number] => 13/875542
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14577
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875542 | TREATING NEOPLASMS WITH NEUROTOXIN | May 1, 2013 | Abandoned |
Array
(
[id] => 10248331
[patent_doc_number] => 20150133327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'METHOD FOR DETECTING OR MONITORING PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/395459
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10002
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395459
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395459 | METHOD FOR DETECTING OR MONITORING PROSTATE CANCER | Apr 18, 2013 | Abandoned |
Array
(
[id] => 9900993
[patent_doc_number] => 20150056193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'EGFR AND ROS1 KINASE IN CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/394793
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34053
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394793
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394793 | EGFR AND ROS1 KINASE IN CANCER | Apr 17, 2013 | Abandoned |
Array
(
[id] => 9175097
[patent_doc_number] => 20130317082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/857775
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16535
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/857775 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER | Apr 4, 2013 | Abandoned |
Array
(
[id] => 10219823
[patent_doc_number] => 20150104816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'MARKER FOR DETECTING PANCREATIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/401660
[patent_app_country] => US
[patent_app_date] => 2013-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5558
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401660 | MARKER FOR DETECTING PANCREATIC CANCER | Mar 31, 2013 | Abandoned |
Array
(
[id] => 9910373
[patent_doc_number] => 20150065575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'S100A8/A9 as a Diagnostic Marker and a Therapeutic Target'
[patent_app_type] => utility
[patent_app_number] => 14/389237
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17611
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389237
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389237 | S100A8/A9 as a Diagnostic Marker and a Therapeutic Target | Mar 14, 2013 | Abandoned |
Array
(
[id] => 8951148
[patent_doc_number] => 20130196929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS'
[patent_app_type] => utility
[patent_app_number] => 13/827567
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13737
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827567
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/827567 | SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS | Mar 13, 2013 | Abandoned |
Array
(
[id] => 8950574
[patent_doc_number] => 20130196355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia'
[patent_app_type] => utility
[patent_app_number] => 13/803561
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3710
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803561
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/803561 | Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia | Mar 13, 2013 | Abandoned |